dermatology
Psoriasis

News in brief: Ustekinumab subsidised for kids with severe CPP; Skin imaging centre of excellence gets $2.5m funding; Covid chilblain mechanism revealed

Ustekinumab subsidised for kids with severe chronic plaque psoriasis Ustekinumab (Stelara) is now available on the PBS for the treatment of paediatric patients with severe chronic plaque psoriasis (CPP). The drug was recommended for listing by the PBAC at its March meeting on the basis that  that ustekinumab provides, for some patients, a significant improvement ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic